Compound ID | 3670
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Unknown |
| Target Pathogen: | Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pyogenes |
| Description: | Benzimidazol-2-one derivative antibacterial scaffold with sulfonyl-piperazine substitution pattern showing broad-spectrum antibacterial activity. |
| Institute where first reported: | Sichuan Provincial People's Hospital |
| Year first mentioned: | 2015 |
| Highest development stage: | Discovery |
| Development status: | Experimental |
| External links: | |
| Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/132525565 |
| Citation: | https://patents.google.com/patent/CN106798740B/en?oq=CN106798740B |
| Patent: | CN106798740B |